SCHEDULE 13G

CUSIP Number(s):

738920305

1

Names of Reporting Persons

Lance Friedman

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,979,709.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,979,709.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

107,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

7.92 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Includes 107,323 shares of common stock shares with a floor price of $7.92 per share. The Reporting Person also has Preferred Stock convertible into common stock with which contain a blocker prohibiting their conversion if it would result in the holder owning more than 9.99% of the outstanding common stock.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Aspire Biopharma Holdings, Inc.

(b)

Address of issuer's principal executive offices:

194 Candelaro Drive, #233, Humacao, Puerto Rico, 00791

Item 2.

(a)

Name of person filing:

Lance Friedman

(b)

Address or principal business office or, if none, residence:

25 N Market Street, Suite 205, Jacksonville, Florida 32202

(c)

Citizenship:

United States

(d)

Title of class of securities:

Common Stock

(e)

CUSIP No.:

738920305

Item 4.

Ownership

(a)

Amount beneficially owned:

(b)

Percent of class:

7.92 %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

107,323

(ii) Shared power to vote or to direct the vote:

N/A

(iii) Sole power to dispose or to direct the disposition of:

107,323

(iv) Shared power to dispose or to direct the disposition of:

N/A

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lance Friedman

Signature:	/s/ Lance Friedman
Name/Title:	Lance Friedman
Date:	08/06/2026